David Friedberg

Because years ago, he sold a company to GSK saying resveratrol would reverse aging.

Because years ago, he sold a company to GSK saying resveratrol would reverse aging.

And, you know, he made $720 million on that.

And, you know, he made $720 million on that.

It didn't end up working.

It didn't end up working.

And he's promoted certain supplement companies and so on.

And he's promoted certain supplement companies and so on.

So I want to preface with that before I kind of underwrite what he's saying with this next thing.

So I want to preface with that before I kind of underwrite what he's saying with this next thing.

But he's a co-founder of a company called Life Biosciences.

But he's a co-founder of a company called Life Biosciences.

And they've reached a major agreement with the FDA to be the first company to treat humans with Yamanaka factors.

And they've reached a major agreement with the FDA to be the first company to treat humans with Yamanaka factors.

Specifically what they're doing is they're going to be delivering these Yamanaka factors.

Specifically what they're doing is they're going to be delivering these Yamanaka factors.

These are these proteins.

These are these proteins.

that rejuvenate cells and make them youthful again into the eye.

that rejuvenate cells and make them youthful again into the eye.